Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rang in aandelen #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Aandeelprijs
$0.01142111
Laatst gesynchroniseerd: 2025-03-21
Marktkapitalisatie
$930.66K
Verandering (1 dag)
0.18%
Verandering (1 jaar)
-69.73%
Land
IE
Handel Ovoca Bio plc (OVXA)

Categorie

P/B-ratio voor Ovoca Bio plc (OVXA)
P/B-ratio op September 2026 TTM: 3.38
Volgens de meest recente financiële rapporten en aandelenkoers van Ovoca Bio plc is de huidige P/B-ratio (TTM) 3.38. Eind 2022 had het bedrijf een P/B-ratio van 0.64.
P/B-ratiohistoriek voor Ovoca Bio plc van 2001 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 3.38 1,025.17%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
6.5144 92.99%
US
7.3983 119.18%
NL
8.5918 154.53%
US
3.9974 18.42%
AU
- -
CH